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Antioxidant therapy reverses impaired graft
healing in hypercholesterolemic rabbits
Michael A. Rosenbaum, MD,a,c Keiko Miyazaki, MD,a Scott M. Colles,a and
Linda M. Graham, MD,a,b Cleveland, Ohio
Objective: Limited endothelial cell (EC) coverage and anastomotic intimal hyperplasia contribute to thrombosis and
failure of prosthetic grafts. Lipid accumulation and lipid oxidation are associated with decreased EC migration and
intimal hyperplasia. The goal of this study was to assess the ability of antioxidants to improve graft healing in
hypercholesterolemic animals.
Methods: Rabbits were placed in one of four groups: chow plus N-acetylcysteine (NAC), chow plus probucol, chow with
1% cholesterol plus NAC, or chow with 1% cholesterol plus probucol. After 2 weeks, expanded polytetrafluoroethylene
grafts (12 cm long 4-mm internal diameter) were implanted in the abdominal aorta. Grafts were removed after 6 weeks
and analyzed for cholesterol content, EC coverage, anastomotic intimal thickness, and the cellular composition of the
neointima. Plasma samples were obtained to assess systemic oxidative stress. The data were compared with previously
reported data from animals fed diets of chow and chow with 1% cholesterol.
Results: Prosthetic grafts from rabbits fed chow with 1% cholesterol had significantly greater anastomotic intimal
thickening and lower EC coverage than grafts from rabbits fed a regular chow diet. In hypercholesterolemic rabbits,
antioxidant therapy decreased global oxidative stress as evidenced by a 40% decrease in plasma thiobarbituric acid reactive
substances. In rabbits fed the chow with 1% cholesterol diet, NAC decreased intimal hyperplasia at the proximal
anastomosis by 29% and significantly increased graft EC coverage from 46% to 71% (P .03). Following a similar pattern,
probucol decreased intimal hyperplasia by 43% and increased graft EC coverage to 53% in hypercholesterolemic rabbits.
Conclusions: Global oxidative stress and anastomotic intimal hyperplasia are increased, and endothelialization of
prosthetic grafts is significantly reduced in rabbits fed a high-cholesterol diet. Antioxidant treatment improves EC
coverage and decreases intimal hyperplasia. Reducing oxidative stress may promote healing of prosthetic grafts. ( J Vasc
Surg 2010;51:184-93.)
Clinical Relevance:Hypercholesterolemia is associated with an increased inflammatory response, elevated oxidative stress,
and increased intimal hyperplasia after stent or vein graft placement in animal models and in humans. Reduced
endothelialization is seen after stent or graft placement in hypercholesterolemic animals, and reduced endothelial cell
growth and patency of endothelial cell-seeded grafts is found in humans with elevated serum lipid levels. Our results
suggest that antioxidants are effective in reducing this pathologic response and in improving graft healing.Peripheral arterial disease (PAD) is a devastating disor-
der with a major effect on quality of life. In the United
States, 8 million individuals aged 40 years have PAD.1
Because the population is aging, the number of Americans
with PAD and the number of peripheral vascular interven-
tions performed each year will increase. Intervention may
take the form of angioplasty, endarterectomy, or autolo-
gous or prosthetic bypass grafting. The long-term patency
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184after any intervention is compromised by the thromboge-
nicity of the prosthetic material or injured luminal surface,
development of intimal hyperplasia (IH), and limitation of
inflow or outflow due to extension or progression, or both,
of atherosclerotic disease.
After implantation of a prosthetic graft, macrophages
infiltrate the graft, lipids are deposited, endothelial cells
(ECs) and smooth muscle cells (SMCs) migrate from the
adjacent artery, and extracellular matrix is produced. In the
inflammatory response to graft placement, macrophages
are activated and produce reactive oxygen species (ROS).
Excessive ROS production overwhelms the endogenous
antioxidant defense mechanisms and leads to the oxidation
of macromolecules such as DNA, proteins, carbohydrates,
and lipids.2
Lipids that accumulate in the graft, particularly at the
anastomoses,3 are oxidized. Lipid oxidation products, but
not native lipids or lipoproteins, cause cellular dysfunc-
tion in vitro, including inhibition of EC migration,4
stimulation of SMC proliferation,5 and increased platelet-
derived growth factor (PDGF) and collagen production
by SMCs,6,7 which could impair graft healing in vivo. Studies
have confirmed that prosthetic graft material induces
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lipid oxidation products accumulate in vascular grafts in
vivo.9 In a previous rabbit study, hypercholesterolemia
impaired prosthetic graft healing and was associated with
increased anastomotic IH, macrophage infiltration, and
decreased endothelialization of the graft.10 Clinical reviews
suggest that elevated serum cholesterol decreases graft
patency in humans.11,12
The mechanism by which hypercholesterolemia ad-
versely affects graft healing may be attributable, in part,
to oxidative stress. Oxidized LDL (oxLDL) inhibits EC
migration by several mechanisms, including stimulation
of ROS production by ECs.13 The inhibitory effects of
oxLDL on EC migration in vitro can be reversed with
superoxide dismutase and nicotinamide adenine dinucle-
otide phosphate (NAD[P]H) oxidase inhibitors.13 SMC
proliferation is mediated, in part, by SMC PDGF recep-
tor activation in response to ROS, and antioxidant treat-
ment decreases PDGF signaling and SMC proliferation
in vitro.14
We postulated that hypercholesterolemia adversely af-
fects prosthetic graft healing in vivo by increasing oxidative
stress and that this oxidative stress inhibits EC migration
and stimulates SMC proliferation. In the present study, we
evaluated the ability of N-acetylcysteine (NAC), a cell-
permeable antioxidant with direct and indirect antioxidant
activity,15,16 and probucol, an antioxidant with weak lipid-
lowering activity, to block the adverse effects of hypercho-
lesterolemia on prosthetic graft healing.
MATERIALS AND METHODS
The protocol for this animal study was approved by the
Institutional Animal Care and Use Committee, and all
procedures and care complied with the Guide for the Care
and Use of Laboratory Animals (National Institutes of
Health Publication No. 85-23, 1996).
Study groups. Adult New Zealand white rabbits (3.5
to 4.5 kg, Myrtle’s Rabbitry, Thompsons Station, Tenn)
were randomized to one of four groups: (1) chow diet
NIH-09 containing 2.4% fat (chow; Zeigler Brothers Inc,
Gardners, Penn) plus NAC (250 mg/kg/d; MP Biomedi-
cals LLC, Solon, Ohio), (2) high cholesterol (HC) diet,
consisting of NIH-09 containing 2.4% fat supplemented
with 1% (wt/wt) cholesterol, plus NAC, (3) chow plus
probucol (280 mg/kg/d; Daiichi Pharmaceuticals Co,
Ltd, Tokyo, Japan), or (4) HC plus probucol. Rabbits fed
chow andHCdiets, without drug therapy, which were used
during an overlapping time period in a previously reported
study, were used for comparison.10 NAC was dissolved in
apple juice (pH, 7.0-7.4) and administered by oral gavage
once daily. Probucol was mixed in applesauce and admin-
istered orally once daily. Rabbits were fed the assigned diet
and medication 2 weeks before graft placement.
Graft implantation and removal. At graft implanta-
tion, anesthesia was induced with ketamine hydrochloride
(40 mg/kg) and xylazine (20 mg/kg). The rabbit was
intubated, mechanically ventilated, and maintained on
1.25% to 1.5% isoflurane throughout the procedure. Beforegraft placement, the rabbits were anticoagulated with hep-
arin sodium (150 U/kg). Expanded polytetrafluoroethyl-
ene (ePTFE) grafts (W.L. Gore and Associates, Flagstaff,
Ariz), 10- to 12-cm long and 4-mm internal diameter, were
anastomosed end-to-end to the abdominal aorta between
the celiac axis and the superior mesenteric artery and end-
to-side to the infrarenal aorta just proximal to the aortic
bifurcation, as previously described.10
For 6 weeks after implantation, the rabbits were main-
tained on the assigned diet and medication. No anticoagu-
lants or antiplatelet agents were administered after implan-
tation. At 6 weeks, the rabbits were anesthetized and
anticoagulated with heparin sodium (200 U/kg). An infu-
sion catheter was inserted into the proximal descending
aorta, and the graft was flushed as previously described.10
The grafts from half the rabbits were perfusion-fixed with
4% paraformaldehyde and processed for immunohisto-
chemistry and scanning electron microscopy (SEM), as
previously described.10 The remaining grafts were removed
for lipid extraction and quantitation.
Plasma biochemical assays. Plasma was procured at
the time of graft implantation and at the conclusion of
the study to measure cholesterol, high-density lipopro-
tein (HDL), and thiobarbituric acid-reactive substances
(TBARS). After the addition of butylated hydroxytoluene
(227 mol/L), the plasma was stored under nitrogen gas
(N2) at 80°C until analyzed.
Total plasma cholesterol concentration was determined
using a cholesterol oxidase method (Infinity Cholesterol
Reagent; Thermo Fisher Scientific Inc, Waltham, Mass).
To determine the HDL level, the low-density/very-low-
density lipoprotein fraction was precipitated using magne-
sium chloride and dextran,17 and the supernatant contain-
ing the HDL fraction was quantitated using a cholesterol
oxidase method. Lipid peroxidation was measured as
TBARS.18 To prevent oxidation during the assay, 100-L
aliquots of plasma were transferred to tubes containing 1
mol of butylated hydroxytoluene. To each sample, 500
L of 1% thiobarbituric acid and 500 L of 25% trichloro-
acetic acid were added. The samples were incubated at
90°C for 60 minutes, centrifuged at 820g for 20 minutes,
and then TBARS levels were quantified using a spectroflu-
orometric method (ex  515 nm, em  553 nm) with a
standard curve prepared using malondialdehyde.
Tissue lipid extraction. Lipids from the graft and
aorta were extracted as previously described.10 Briefly, the
aorta and graft were cut into segments containing the
descending thoracic aorta, proximal anastomosis, midgraft,
distal anastomosis, and distal abdominal aorta. The tissue
was minced, and the lipids were extracted using chloro-
form, methanol, and water in a 2:2:1.8 ratio.19 After phase
separation, the organic layer was removed and dried un-
der N2.
Tissue cholesterol content. Total cholesterol from
graft and aortic segments was measured by high-performance
liquid chromatography (HPLC).10,20 The extracted sam-
ples were resuspended in ethanol, and 10-L aliquots were
added to 200 L of phosphate buffered saline containing 5
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standard. Cholesterol oxidase (0.1 U) and cholesterol es-
terase (0.1 U) were added to 50 L of reaction mixture
(150 mmol/L sodium phosphate, 30 mmol/L sodium
taurocholate, 1 mmol/L polyethylene glycol) to determine
total cholesterol. The sterols were extracted using sodium
chloride (4 mol/L, 250 L) and acetonitrile (500 L).
After phase separation, the supernatant was analyzed using
reverse-phaseHPLC (Nova-Pak C18 3.9 75mm;Waters
Corp, Milford, Mass). Methanol/acetonitrile (1:1) was
used as the eluent at a flow rate of 1mL/minwith detection
at 235 nm.
Morphologic assessment of grafts. After removal,
graft and aortic segments were processed as previously
described.10 Briefly, the grafts were fixed overnight in 4%
paraformaldehyde and divided longitudinally, with half
used for SEM and the other half for immunohistochemis-
try. SEM samples were dehydrated, dried, sputter-coated
with gold, and examined using a JSM-6930 microscope
(JEOL, Peabody, Mass). Endothelial coverage was ana-
lyzed using SEM, confirmed by immunohistochemistry as
previously described, and reported as a percentage (endo-
thelialized surface area/total luminal surface area 
100).10 Each area was examined under low-power magni-
fication (15), then high-power magnification (1500)
was used to verify the presence or absence of ECs.
To assess for IH, the tissue segments were embedded in
paraffin, sectioned longitudinally, and stained with hema-
toxylin and eosin. The proximal anastomotic region was
imaged, and the neointima was measured by an observer
blinded to the treatment group at the thickest point be-
tween 1.5 and 2.5 mm from the end of the graft to avoid
suture line distortion, as previously described.10 The results
were reported as the intimal/graft thickness (I/G) ratio.
Normalizing the graft thickness mathematically corrected
for any mild tissue angulation that occurred during the
embedding process.
Immunostaining for macrophages and nitrotyrosine.
The presence of macrophages or nitrotyrosine was assessed
by immunohistochemistry as previously described.10 Anti-
body to RAM-11 (1:100; DAKO, Glostrup, Denmark) or
human nitrotyrosine (1:200; Cayman Chemical, Ann Ar-
bor, Mich) was used to identify macrophages or nitroty-
rosine, respectively. Diaminobenzidine (DAB Kit; Vector
Laboratories, Burlingame, Calif) was used to visualize an
avidin-conjugated secondary antibody (ABC Kit; Vector
Laboratories).
Macrophage accumulation within the graft and neoin-
tima was quantitated by identifying cells positive for RAM-
11. Positively stained and nonstained cells were counted in
three 0.0625-mm2 areas in distinct regions of the graft by
two observers blinded to treatment group. The data were
expressed as total cells or percentage of macrophages in a
0.0625-mm2 area of graft or neointima. Nitrotyrosine was
used as a marker of peroxynitrite generation, which forms
when nitric oxide reacts with superoxide. Sections of tissue
from all dietary groups were processed simultaneously to
minimize variations in staining technique. Three observersblinded to the treatment group qualitatively scored the
nitrotyrosine staining on a scale from 1 to 5, and the scores
were averaged.
Statistical analysis. Results were presented as the
mean standard error of the mean. Data were evaluated by
	2 test, t test, or analysis of variance, followed by Tukey
post hoc multiple comparison using Prism 5.0 software
(GraphPad Software Inc, San Diego, Calif). P  .05 was
considered statistically significant.
RESULTS
The study used 73 rabbits, including 36 rabbits fed
chow (n  18) and HC (n  18) diets that were
implanted during an overlapping time period but re-
ported previously,10 and 37 rabbits were allocated to the
additional four groups. Rabbits were assigned to a treat-
ment group 2 weeks before graft implantation and main-
tained on the assigned diet and medication until 6 weeks
after placement. The study groups each were initially as-
signed an equal number of rabbits, but respiratory ailments
developed in some rabbits before graft implantation and
were excluded from further analysis.
In the chow plus NAC group (n  7), the surgical
mortality was 14%, with one rabbit euthanized for failure to
thrive, defined as weight loss 25% of the preoperative
weight. In the chow plus probucol group (n  11), the
surgical mortality was 27%, with two deaths intraopera-
tively and one rabbit euthanized due to hind-limb paralysis.
In theHC plus NAC group (n 10), the surgical mortality
was 30%, with three rabbits euthanized for failure to thrive.
In the HC plus probucol group (n  9), the surgical
mortality was 11%, with one rabbit euthanized for hind-
limb paralysis. Although the operative mortality varied
among the groups, the mortality rate was within an accept-
able range for this model, and the differences were not
statistically significant. No deaths were due to graft occlu-
sion. Data from grafts in rabbits fed chow (n 18) andHC
(n  18) diets were included for comparison.10
The preoperative and postoperative data for all study
groups are summarized in Table I. The rabbit ages and
weights were similar across all groups. Compared with the
chow diet, the HC diet increased plasma cholesterol levels
20-fold at the time of graft implantation and30-fold at
6 weeks after implantation. NAC and probucol did not
affect the plasma cholesterol at graft implantation or re-
moval. NAC had no effect on HDL levels, but probucol
treatment resulted in a 35% decrease in HDL levels in
rabbits fed a chow diet (P 
 .01) and a 49% decrease in
HDL levels in rabbits fed the HC diet (P 
 .001).
Tissue cholesterol content. Tissue lipids were ex-
tracted from the descending thoracic aorta, proximal anas-
tomosis, midgraft, distal anastomosis, and distal abdominal
aorta, and quantitated. Aortic and graft cholesterol content
was significantly increased in rabbits fed an HC diet com-
pared with chow (Fig 1,A and B).10 NAC and probucol did
not affect the aortic or graft tissue cholesterol levels in
normocholesterolemic rabbits. In hypercholesterolemic
rabbits, NAC and probucol significantly reduced the cho-
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cholesterol at the proximal anastomosis, but neither drug
affected the cholesterol of the midgraft, distal anastomosis,
or distal aorta (Fig 1, A and B).
Plasma TBARS levels. TBARS levels were deter-
Table I. Preoperative and postoperative data (presented a
Group No. Age, mon
Weight, kg
At implant At re
Chow (control)a 13 8.1  0.5 3.8  0.1 3.9
NAC 6 7.8  0.5 4.3  0.2 4.4
Probucol 8 7.2  0.6 4.2  0.1 4.3
HCa 13 8.4  0.4 4.0  0.1 3.9
NAC 7 7.5  0.3 4.1  0.2 3.7
Probucol 8 8.2  0.4 4.4  0.1 4.0
HC, High cholesterol; HDL, high-density lipoprotein; NAC, N-acetylcyste
aData from a previous study.10
bSignificant difference (P 
 .05) between chow control group and all HC g
cSignificant difference (P 
 .05) between chow  NAC group and all HC
dSignificant difference (P 
 .05) between chow  probucol group and all H
eSignificant difference (P 
 .05) between chow control group and chow 
fSignificant difference (P 
 .05) between HC and HC  probucol group.
Fig 1. To measure tissue cholesterol content, lipids were ex-
tracted from (A) aortic and (B) graft samples and tissue cholesterol
levels were determined using high-performance liquid chromatog-
raphy. Levels are reported as g/mg tissue (wet weight) and
expressed as themean standard error for each tissue segment and
rabbit group: chow (n  3), chow plus N-acetylcysteine (NAC;
n 2), chow plus probucol (n 3), high cholesterol (HC, n 3),
HC plus NAC (n  3), and HC plus probucol (n  3). *P 
 .05.
#P 
 .005. ††Data from previous study.10mined in plasma samples obtained at graft removal as ameasure of global oxidative stress. TBARS in the chow
group were significantly lower than in the HC group (P 
.03), and antioxidants did not further decrease TBARS
levels in chow-fed animals (Fig 2). In hypercholesterolemic
animals, TBARS levels (nmol MDA/mL) were 1.04 
0.40 in the HC group and were decreased to 0.61  0.08
(P  .1) and 0.61  0.07 (P  .1) by NAC and probucol,
respectively (Fig 2). The trend indicates decreased global
oxidative stress with NAC and probucol treatment, and the
TBARS levels in all hypercholesterolemic rabbits receiving
antioxidants (NAC or probucol) were significantly lower
than in the HC group (P  .05).
Endothelialization of ePTFE grafts. SEM was used
to determine EC coverage of grafts implanted for 6 weeks.
As reported previously, hypercholesterolemia significantly
decreased EC coverage compared with chow.10 NAC did
not affect endothelial coverage, but probucol decreased
endothelialization in normocholesterolemic rabbits (Fig 3,
an  standard error)
Plasma cholesterol, mg/dL
l Total at implant Total at removal HDL at removal
34.0  4.4b 18.2  3.0b 37.1  3.5
33.7  5.3c 33.0  5.1c 39.3  2.5
31.3  4.8d 25.8  3.6d 24.2  2.7e
689.4  30 1087.7  116.5 45.5  2.9
954.2  198.7 1118.9  94.2 36.8  2.9
993.1  90.1 1257.7  131.8 23.4  3.2f
.
s.
oups.
col group.
Fig 2. Plasma thiobarbituric acid reactive substance (TBARS)
levels were determined 6 weeks postoperatively and reported as
nmol MDA/mL. Values are expressed as the mean  standard
error for each rabbit group: chow (n 7), chow plusN-acetylcys-
teine (NAC; n 6), chow plus probucol (n 8), high cholesterol
(HC, n  6), HC plus NAC (n  7), and HC plus probucol (n 
8). *P
 .05 between chow andHC groups. ††Data from previous
study.10s me
mova
 0.1
 0.2
 0.2
 0.1
 0.1
 0.1
ine.
roups
group
C gr
probuA). In hypercholesterolemic rabbits, NAC significantly im-
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in HC rabbits to 71%  9% in HC plus NAC rabbits (P 
.03). Probucol treatment showed a trend toward improved
endothelialization of ePTFE grafts in hypercholesterolemic
rabbits, with coverage of 53% 7% (Fig 3, A). Overall, the
EC coverage of ePTFE grafts was significantly higher in
hypercholesterolemic rabbits receiving antioxidant therapy
than in the HC group (P  .05).
Anastomotic IH. Anastomotic IH was measured in
hematoxylin and eosin-stained tissue sections of the proxi-
mal anastomosis. IH was significantly lower in the chow
group than the HC group (P 
 .05), and antioxidants did
not further decrease the IH (Fig 3, B). NAC and probucol
decreased the I/G ratio in hypercholesterolemic rabbits
from 0.76  0.29 in the HC group10 to 0.54  0.05 and
0.43  0.13 (Fig 3, B), respectively. The data suggested
Fig 3. Endothelialization of expanded polytetrafluoroethylene
(ePTFE) grafts and total luminal area were determined by scanning
electron microscopy. A, Endothelialization was reported as the
percentage of vascular graft covered by endothelium relative to the
total luminal area of the graft and expressed as themean standard
error for each group: chow (n  10), chow plus N-acetylcysteine
(NAC; n 4), chow plus probucol (n 5), high cholesterol (HC,
n  11), HC plus NAC (n  4), and HC plus probucol (n  5).
*P 
 .05 between chow and chow plus probucol or HC groups.
#P
 .05 between HC and HC plus NAC groups. B, Anastomotic
intimal hyperplasia was measured on histologic sections between
1.5 and 2.5 mm from the graft end and expressed as the mean 
standard error for each group: chow (n 7), chow plus NAC (n
4) chow plus probucol (n  5), HC (n  4), HC plus NAC (n 
4), and HC plus probucol (n  5). *P 
 .05 between chow and
HC groups. ††Data from previous study.10that hypercholesterolemic rabbits receiving antioxidanttherapy might have had less development of IH than the
HC group (P  .1).
Macrophage accumulation. Macrophage infiltration
and total cellularity of the prosthetic graft and neointima
were assessed using tissue sections stained for RAM-11 and
counterstained with hematoxylin. The total number of cells
in the graft or neointima was not significantly different
between groups, except for increased graft cells in the chow
plus NAC group (Table II). The percentage of macro-
phages in the graft and neointima was significantly lower in
the chow group than in the HC group (P 
 .05),10 and
antioxidant therapy did not further decrease macrophage
infiltration in chow-fed rabbits. In hypercholesterolemic
rabbits, NAC decreased the percentage of macrophages in
the graft (P  .06), but probucol did not alter the macro-
phage infiltration (Table II; Fig 4).
Nitrotyrosine staining. Nitrotyrosine is the stable
end product of tissue nitration by peroxynitrite, a potent
oxidant. As a result, nitrotyrosine can be used as an indica-
tor of tissue oxidative stress. The nitrotyrosine staining in
the graft and neointima was lower in the chow group
compared with the HC group, and antioxidants did not
further decrease the nitrotyrosine staining. NAC, but not
probucol, qualitatively decreased nitrotyrosine staining in
grafts from hypercholesterolemic rabbits (Fig 5). The graft
nitrotyrosine scores from blinded observers were 1.90 
0.64, 0.33  0.17, and 2.45  0.94 in the HC, HC plus
NAC, and HC plus probucol group, respectively (P  .06
for HC vs HC plus NAC). The nitrotyrosine scores for the
neointima followed a similar pattern. NAC reduced the
amount of nitrotyrosine present in the graft and neointima
of hypercholesterolemic rabbits, but probucol had no ef-
fect.
DISCUSSION
Prosthetic graft healing is impaired by hypercholester-
olemia in vivo.3,10 The mechanism by which hypercholes-
terolemia impairs graft healing remains unclear but may be
partly caused by oxidized lipids in the graft. Lipid oxidation
products accumulate in prosthetic grafts,9 and the adverse
effects of oxidized lipids on SMC proliferation and EC
migration have been demonstrated in vitro. OxLDL stim-
ulates SMC proliferation and enhances SMC collagen pro-
duction.5,7 OxLDL also inhibits ECmigration, but this can
be reversed by treating cultured cells with antioxidants.13
Graft healing in hypercholesterolemic rabbits was im-
proved by -tocopherol, a chain-breaking antioxidant, but
the mechanism was unclear because -tocopherol also de-
creased tissue cholesterol content.10 Evidence suggests that
two-electron redox reactions are important in atherogene-
sis, but -tocopherol is most protective against one-electron
oxidation reactions.21,22 The antioxidants NAC and pro-
bucol have been shown to reduce intimal hyperplasia and
coronary artery restenosis rates in both animal and human
studies.23,24 This study was undertaken to evaluate the role
of oxidative stress in prosthetic graft healing in hypercho-
lesterolemic animals by using these two potent antioxi-
dants.
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oxidant action. NAC has direct and indirect antioxidant
activity due to its sulfhydryl group.15,16 NAC directly inac-
tivates ROS and hypochlorite by conjugation or reduction
to form NAC radicals.15 NAC also increases glutathione
formation, and glutathione is quantitatively the most im-
portant intracellular antioxidant. Glutathione can react
with peroxynitrite, preventing its accumulation and pro-
tecting against nitrosative stress.25 Peroxynitrite causes cel-
lular damage through peroxidation of membrane lipids,
protein denaturation, and direct DNA damage.25 In addi-
tion, NAC inhibits nuclear factor (NF)-B binding to the
promoter region of several proinflammatory cytokines,26
including tumor necrosis factor-, interleukin (IL)-1,
IL-2, IL-6, IL-8, and monocyte chemotactant protein-1.27
Decreased proinflammatory cytokine levels lead to de-
creased macrophage and neutrophil recruitment and acti-
vation.26 NAC inhibits NF-B expression and leads to
decreased SMC proliferation and neointimal formation.28
The antioxidant activity of probucol is mediated by the
heme oxygenase-1 pathway, as opposed to direct free rad-
ical scavenging.22 Evidence from mouse and rabbit models
indicates the sulfur component of probucol is critical for
protection from ROS-induced atherogenesis.22 Overall,
the results suggest that NAC and probucol therapy is
associated with a decrease in oxidative stress in hypercho-
lesterolemic rabbits.
The present study used plasma TBARS levels and tissue
nitrotyrosine staining to assess the effectiveness of antioxi-
dant therapy. Plasma TBARS levels decreased by approxi-
mately 42% in hypercholesterolemic rabbits treated with an
antioxidant, suggesting decreased global oxidative stress.
NAC also decreased nitrotyrosine staining in grafts of hy-
percholesterolemic rabbits, indicating decreased local oxi-
dative stress. The decreased peroxynitrite formation was
likely due to increased glutathione formation and decreased
Table II. Cellularity and macrophage accumulation of the
Group No.
Neoin
Total cellsa
Chow, controlc 6 163  19
NAC 3 142  13
Probucol 5 184  28
HCc 5 195  20
NAC 4 130  21
Probucol 5 133  11
HC, High cholesterol; NAC, N-acetylcysteine.
aTotal cell count/0.0625 mm2.
bPercent of total number of cells identified as macrophages/0.0625 mm2.
cData from a previous study.10
dSignificant difference (P 
 .05) between chow control group and all HC g
eSignificant difference (P 
 .05) between chow control and all HC groups.
fSignificant difference (P 
 .05) between chow control and chow  NAC g
gSignificant difference (P 
 .05) between chow  NAC and all HC groups
hSignificant difference (P 
 .05) between chow  probucol all HC groups
iSignificant difference (P 
 .05) between chow  probucol and all HC gro
jNonsignificant difference (P  .06) between HC and HC  NAC.macrophage accumulation in the grafts of NAC-treatedrabbits. Probucol did not show a similar decrease in nitro-
tyrosine staining, possibly because this qualitative analysis
has low sensitivity, and probucol has a different mechanism
of action.
Hypercholesterolemia decreases graft endothelializa-
tion,10 and in this study, NAC significantly improved graft
endothelialization in hypercholesterolemic rabbits, and
probucol showed a potential trend toward improved graft
endothelialization. The decreased endothelialization by
probucol in chow-fed rabbits may be due to decreased
HDL, which has been associated with probucol treat-
ment.29,30 In vitro studies show that HDL stimulates EC
migration,31 and in vivo studies show decreased endothe-
lialization after arterial injury in apolipoprotein A-I defi-
cient mice with markedly decreased HDL levels.32 In our
study, HDL levels were significantly decreased in rabbits
fed the chow diet or HC diet that received probucol
treatment. Thus, the potentially promigratory effects of
probucol’s antioxidant activity may be counteracted by the
adverse effects of HDL lowering.
Our previous study showed that hypercholesterolemia
increases IH,10 and the present study demonstrates that
NAC and probucol are associated with a trend toward
decreased anastomotic IH in hypercholesterolemic rabbits.
These data are consistent with previous studies showing
decreased IH with NAC or probucol after arterial injury
in rabbits29,33-35 and after coronary angioplasty in hu-
mans.23,24 Our probucol results were inconsistent with a
previous report by Baumann et al36 that showed no change
in intimal thickening with probucol treatment but a signif-
icantly decreased number of SMCs and macrophages. Our
study found no difference in cellularity, suggesting that the
decrease in IH with antioxidants is due to a proportional
decrease in cell accumulation and extracellular matrix dep-
osition. OxLDL increases PDGF production, which can
result in SMC proliferation and increased collagen produc-
intima and graft (presented as mean  standard error)
Graft
Macrophageb Total cellsa % Macrophageb
0  0.3d 146  30 0  0.2e
0  0.0 300  50f 1  0.4g
2  1.1h 235  42 4  2.0i
26  9.9 159  28 30  6.0
23  2.9 192  16 18  2.0j
16  4.1 186  31 28  3.6
.neo
tima
%
roups
roup.
.
.
ups.tion.6,7,14 NAC and probucol both reduce PDGF signaling
ucol (
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arterial injury.14,37
NAC and probucol had beneficial effects on graft heal-
ing in our hypercholesterolemic rabbits, but NAC was
more effective than probucol. The antioxidants decreased
systemic oxidative stress, but only NAC showed decreased
local oxidative stress levels. Given the trend toward de-
creased oxidative stress levels without significant change in
plasma cholesterol levels, the effects of NAC and probucol
Fig 4. To show macrophage infiltration, graft sections
were processed for immunohistochemistry and stained
Representative sections (original magnification 100)
(B) high cholesterol (HC) diet (n  5), (C) chow plus
(E) chow plus probucol (n  5), and (F) HC plus probon graft healing are potentially due to their antioxidantactivity. The mechanism for decreased tissue cholesterol
deposition at the proximal anastomosis in hypercholester-
olemic rabbits treated with NAC is unclear because not all
segments of tissue were affected in the same manner. The
inconsistency may be related to decreased inflammatory
infiltrate and improved endothelialization at the proximal
anastomosis, but limited benefit at the distal anastomosis
due to turbulent blood flow. The differences in graft heal-
ing between NAC and probucol groups have been due to
rwent perfusion-fixation with 4% paraformaldehyde and
g mouse anti-rabbit macrophage antibody (RAM-11).
own from each rabbit group: (A) chow diet (n  6),
tylcysteine (NAC; n  3), (D) HC plus NAC (n  4),
n  5). ††Data from previous study.10unde
usin
are sh
N-acetheir distinct mechanisms of action as well as the HDL-
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Volume 51, Number 1 Rosenbaum et al 191lowering effect of probucol, which would be expected to
negatively affect graft endothelialization. Despite different
mechanisms of action, NAC and probucol are associated
with beneficial effects on prosthetic graft healing in hyper-
cholesterolemia, suggesting the potential importance of
their antioxidant activity.
Hypercholesterolemia led to impaired graft healing in
our rabbit model, and elevated serum lipids adversely affect
EC growth and graft patency in humans.38 In the rabbit
Fig 5. Nitrotyrosine staining. After perfusion-fixation
immunohistochemistry and stained using mouse anti-hu
magnification 100) are shown from rabbits fed (A) reg
5), (C) chow plus N-acetylcysteine (NAC; n  2), (D) H
(F) HC plus probucol (n  5).model, antioxidant therapy ameliorated the reduced endo-thelialization and increased IH due to hypercholesterol-
emia. Extrapolation of these findings to humans should be
done with caution because of differences in graft healing.
Analysis of ePTFE grafts removed from patients shows ECs
only in the first few millimeters from the anastomoses,39
but in ePTFE grafts seeded with venous ECs before im-
plantation, endothelium lines the middle portion of these
grafts years later.38 Furthermore, patency of EC-seeded
grafts is significantly improved compared with unseeded
% paraformaldehyde, graft sections were processed for
itrotyrosine antibody. Representative sections (original
how diet (n  3), (B) high cholesterol (HC) diet (n 
lus NAC (n  3), (E) chow plus probucol (n  5), andwith 4
man n
ular c
C pePTFE grafts, and surface thrombogenicity is reduced.40
JOURNAL OF VASCULAR SURGERY
January 2010192 Rosenbaum et alThe current study showed that altering the environment
into which a graft is placed had a dramatic effect on healing.
This raises the possibility that long-term modification of
oxidative stress might promote optimal graft healing in
humans, with resultant improvement in patency.
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